Suppr超能文献

药物政策、危害与人权:理性主义的进路

Drug policy, harm and human rights: a rationalist approach.

机构信息

School of Social Policy, Sociology and Social Research, University of Kent, Medway, United Kingdom.

出版信息

Int J Drug Policy. 2011 May;22(3):233-8. doi: 10.1016/j.drugpo.2011.02.003. Epub 2011 Apr 9.

Abstract

BACKGROUND

It has recently been argued that drug-related harms cannot be compared, so making it impossible to choose rationally between various drug policy options. Attempts to apply international human rights law to this area are valid, but have found it difficult to overcome the problems in applying codified human rights to issues of drug policy.

METHOD

This article applies the rationalist ethical argument of Gewirth (1978) to this issue. It outlines his argument to the 'principle of generic consistency' and the hierarchy of basic, nonsubtractive and additive rights that it entails. It then applies these ideas to drug policy issues, such as whether there is a right to use drugs, whether the rights of drug 'addicts' can be limited, and how different harms can be compared in choosing between policies.

RESULT

There is an additive right to use drugs, but only insofar as this right does not conflict with the basic and nonsubtractive rights of others. People whose freedom to choose whether to use drugs is compromised by compulsion have a right to receive treatment. They retain enforceable duties not to inflict harms on others. Policies which reduce harms to basic and nonsubtractive rights should be pursued, even if they lead to harms to additive rights.

CONCLUSION

There exists a sound, rational, extra-legal basis for the discussion of drug policy and related harms which enables commensurable discussion of drug policy options.

摘要

背景

最近有人认为,药物相关危害无法进行比较,因此无法在各种药物政策选项之间进行理性选择。将国际人权法应用于这一领域的尝试是合理的,但在将编纂的人权应用于药物政策问题方面遇到了困难。

方法

本文将格沃思(Gewirth)的理性主义伦理论点(1978)应用于这一问题。概述了他的论点,即“普遍一致性原则”和由此产生的基本、非减损和附加权利的层次结构。然后将这些想法应用于药物政策问题,例如是否存在使用药物的权利,是否可以限制药物“成瘾者”的权利,以及如何在政策选择之间比较不同的危害。

结果

存在使用药物的附加权利,但前提是该权利不与他人的基本和非减损权利相冲突。那些因强迫而丧失选择是否使用药物自由的人有权接受治疗。他们保留不伤害他人的可执行义务。即使这些政策会对附加权利造成损害,也应该推行减轻对基本和非减损权利的危害的政策。

结论

存在一个合理、理性的法律之外的基础,可用于讨论药物政策和相关危害,从而能够对药物政策选项进行可比较的讨论。

相似文献

1
Drug policy, harm and human rights: a rationalist approach.药物政策、危害与人权:理性主义的进路
Int J Drug Policy. 2011 May;22(3):233-8. doi: 10.1016/j.drugpo.2011.02.003. Epub 2011 Apr 9.
2
5
Ushering in another harm reduction era? Discursive authenticity, drug policy and research.
Drug Alcohol Rev. 2005 Nov;24(6):549-50. doi: 10.1080/09595230500404145.
7
Harm reduction--an ethical imperative.减少伤害——一项道德要求。
Addiction. 2009 Mar;104(3):342-3; discussion 345-6. doi: 10.1111/j.1360-0443.2008.02418.x.
9
Dilemmas in harm minimization.危害最小化中的困境
Addiction. 2009 Mar;104(3):335-9. doi: 10.1111/j.1360-0443.2008.02336.x. Epub 2008 Oct 8.
10
Drug Policy and the Public Good: a summary of the book.毒品政策与公共利益:对本书的概述。
Addiction. 2010 Jul;105(7):1137-45. doi: 10.1111/j.1360-0443.2010.03049.x.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验